University of Massachusetts

Worcester, Massachusetts 30303

11 studies enrolling now · 105 studies all time

What they study most

Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Abdominal Aortic Aneurysms, Abscess, Acute Bacterial Skin and Skin Structure Infections, Acute Ischemic Stroke, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Stroke, Alcoholic Hepatitis

Studies at this site

• Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML — Recruiting now
• A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD — Recruiting now
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• Radiation Free Study — Recruiting now
• Nectero EAST System Clinical Study — Recruiting now
• The Periviable GOALS Decision Support Tool — Recruiting now
• Real-Time Cholangioscopy Artificial Intelligence Evaluation of Biliary Strictures — Recruiting now
• Zenith® Fenestrated+ Clinical Study — Recruiting now
• Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial — Recruiting now
• Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI — Recruiting now
• Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer — Recruiting now
• A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms — Completed
• A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients — Running, not enrolling
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
• A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) — Running, not enrolling
• A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer — Running, not enrolling
• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Running, not enrolling
• SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study — Enrolling by invitation
• Multicenter Phase II Study of Transanal TME (taTME) — Running, not enrolling
• Evaluation of D-Fi for the Treatment of Wounds Due to DEB — Running, not enrolling
• Abemaciclib and Letrozole to Treat Endometrial Cancer — Running, not enrolling
• Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant — Completed
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms — Running, not enrolling
• A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring — Enrolling by invitation
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) — Completed
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study — Completed
• CERENOVUS Neurothrombectomy Devices Registry — Completed
• A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX) — Completed
• Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment — Stopped early
• Alcoholic Hepatitis Network Observational Study — Completed
• Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells — Completed
• A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) — Completed
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer — Completed
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment — Running, not enrolling
• Asthma Link: A Real World Application of School Supervised Asthma Therapy — Completed
• CT (Computerized Tomography) for Late EndovasculAr Reperfusion — Completed
• Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions — Completed
• Treatment With Intent to Generate Endovascular Reperfusion — Completed
• The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke — Completed
• Safety Planning Intervention to Reduce Short Term Risk — Completed
• Trident II Revision Outcomes Study — Stopped early
• pRESET for Occlusive Stroke Treatment — Completed
• Ziprasidone in the Psychosis Prodrome — Completed
• Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions — Stopped early
• Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients — Status unconfirmed